Abstract Background Static [18 F]-F-DOPA PET images are currently used for identifying
patients with glioma recurrence/progression after treatment, although the additional …

Purpose Differentiation between recurrence and radiation necrosis in patients with glioma is
crucial, since the two entities have completely different management and prognosis. The …

Purpose of the present study was to evaluate the role of 18 F-FDOPA PET/CT for predicting
survival in patients with suspected recurrent glioma. Methods A total of 33 previously treated …

Objectives To investigate the value of combined 18F-fluorethyltyrosine-(FET)-PET/MRI for
differentiation between recurrence and treatment-related changes in glioma patients …

Background Amino acid transport imaging with 18F-FDOPA PET is increasingly used for
detection of glioblastoma recurrence. However, a standardized image interpretation for 18F …

Objective: To compare MRI using perfusion and diffusion techniques with 6-[18F]-fluoro-L-3,
4-dihydroxyphenylalanine (18F-FDOPA) positron emission tomography (PET) in the follow …

Objectives Diagnostic accuracy of amino-acid PET for distinguishing progression from
treatment-related changes (TRC) is currently based on single-center non-homogeneous …

Introduction To report the potential value of pre-operative 18 F-FDOPA PET and anatomic
MRI in diagnosis and prognosis of glioma patients. Methods Forty-five patients with a …

BACKGROUND AND PURPOSE: Differentiating glioma recurrence from treatment-induced
necrosis can be a challenge on conventional imaging. This study aimed to assess the …

BACKGROUND AND PURPOSE: Inter-and intratumor heterogeneity and the variable course
of disease in patients with glioma motivate the investigation of new prognostic factors to …